Wu J, Yu H, Shao Y
Department of Abdominal Surgery, Chinese Academy of Medical Sciences, Beijing.
Zhonghua Zhong Liu Za Zhi. 1995 Nov;17(6):438-40.
Carcinoembryonic antigen (CEA) is frequently used in the diagnosis of the colorectal carcinoma. CA242 is a novel unique tumor-associated antigen characterized by higher tumor specificity and sensitivity for colorectal cancer, as compared with other mucin antigens. In this study, preoperative levels of serum CEA and CA242 were measured in 63 cases of colorectal carcinoma. It was disclosed that the positive rate of CA242 was higher than that of CEA, particularly in patients with colon cancer. The combined determination of CEA and CA242 significantly increased the sensitivity and accuracy in the detection of colorectal cancer as compared with the use of CEA alone (P < 0.01). In patients with advanced disease the positive rate was markedly elevated, especially in patients with liver metastasis. The results indicate that the combined use of CEA and CA242 assays is an useful adjunct diagnostic measure for colorectal carcinoma, and is helpful in the assessment of the stage of the disease as well as in making treatment plan.
癌胚抗原(CEA)常用于结直肠癌的诊断。CA242是一种新型独特的肿瘤相关抗原,与其他粘蛋白抗原相比,其对结直肠癌具有更高的肿瘤特异性和敏感性。在本研究中,对63例结直肠癌患者术前血清CEA和CA242水平进行了检测。结果显示,CA242的阳性率高于CEA,尤其在结肠癌患者中。与单独使用CEA相比,联合检测CEA和CA242显著提高了结直肠癌检测的敏感性和准确性(P < 0.01)。在晚期疾病患者中,阳性率明显升高,尤其是肝转移患者。结果表明,联合使用CEA和CA242检测是结直肠癌有用的辅助诊断措施,有助于评估疾病分期以及制定治疗方案。